Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities:
Net income (loss)	$ 25	$ (35)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	44	42
Stock-based compensation expense (Note 9)	57	61
Deferred income tax expense (benefit)	1	(9)
Other, net	16	8
Changes in operating assets and liabilities, net:
Accounts receivable, net, prepaid expenses and other assets	(80)	(90)
Accounts payable, accrued expenses and other liabilities	15	65
Deferred merchant payables	202	212
Income tax receivables/payables, net	(14)	(100)
Deferred revenue	38	36
Net cash provided by (used in) operating activities	304	190
Investing activities:
Capital expenditures, including capitalized website development	(44)	(31)
Other investing activities, net	(2)	0
Net cash provided by (used in) investing activities	(46)	(31)
Financing activities:
Proceeds from the issuance of Term Loan B Facility, net of financing costs (Note 6)	341	0
Principal payments on Term Loan B Facility (Note 6)	(4)	0
Repurchase of common stock related to Merger, including transaction costs (Note 1)	(411)	0
Repurchase of common stock under the share repurchase program (Note 10)	(40)	(25)
Payment of withholding taxes on net share settlements of equity awards	(12)	(14)
Payments of finance lease obligation	(4)	(4)
Net cash provided by (used in) financing activities	(130)	(43)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	20	(7)
Net increase (decrease) in cash, cash equivalents and restricted cash	148	109
Cash, cash equivalents and restricted cash at beginning of period	1,064	1,067
Cash, cash equivalents and restricted cash at end of period	1,212	1,176
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes, net of refunds	15	165
Cash paid during the period for interest	27	20
Supplemental disclosure of non-cash flow financing activities:
Issuance of common stock related to Merger (Note 1)	39	0
Net operating loss carryforwards retained related to Merger (Note 1)	$ 13	$ 0